Non-Invasive Neuromodulation Support for Heart Rate Variability: Guide Published

Nuropod has published an educational guide explaining how vagus nerve stimulation may help support heart rate variability and nervous system recovery, outlining a non-invasive, auricular approach to engaging the vagus nerve.

Sacramento, United States, September 21, 2026 /PressCable/ -- Nuropod has released an in-depth resource covering non-invasive neuromodulation support, outlining a practical approach to supporting heart rate variability through vagus nerve engagement.

More information is available at https://nuropod.com/blogs/articles/how-to-increase-hrv

The move comes as low heart rate variability is increasingly understood as a sign the nervous system is out of balance, making it harder for the body to shift between stress and rest. Nuropod's guide speaks to this, explaining how non-invasive neuromodulation fits into a broader approach to supporting that balance.

The company's latest guide also outlines lifestyle factors known to influence the balance, including consistent sleep timing, slow breathing practices, moderate movement, and reduced sensory or cognitive load, before introducing vagus nerve stimulation through technology such as that used in Nuropod.

Nuropod is a wearable, non-invasive device that clips onto the tragus, the small point of cartilage at the front of the outer ear where a branch of the vagus nerve reaches the skin's surface. The device delivers mild electrical pulses through Parasym's proprietary AVNT™ waveform, designed to support that system. The guide goes on to outline peer-reviewed research on the neuromodulation technology used in Nuropod, noting that individual results may vary.

The AVNT technology has been evaluated across more than 60 completed clinical studies and is the subject of over 100 ongoing research programs, conducted with more than 150 research partners and more than 150 internationally recognized institutions. It has also been tested in randomized, placebo-controlled study designs, supported by peer-reviewed research, more than $10 million in clinical research investment, and over 10,000 hours of research and development spanning more than ten years. The underlying technology has recorded more than 5 million user sessions and is used by more than 1,000 healthcare professionals.

Individuals interested in learning more about non-invasive neuromodulation support can access the full guide at https://nuropod.com/

Disclaimer: Nuropod is classified by the FDA as a non-designated risk device and is not intended to diagnose, treat, cure, or prevent any disease. Clinical research referenced in this article was conducted using Parasym's neuromodulation technology under research conditions. All percentage figures cited reflect findings from specific study populations and should not be interpreted as guaranteed outcomes for all users. Individuals should consult a qualified health professional regarding their personal health needs.

Contact Info:
Name: Victor Kho
Email: Send Email
Organization: Nuropod
Address: 2108 N Street, Sacramento, California 95816, United States
Website: https://nuropod.com/

Source: PressCable

Release ID: 89203964

If there are any deficiencies, discrepancies, or concerns regarding the information presented in this press release, we kindly request that you promptly inform us by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team is committed to addressing any identified issues within 8 hours to guarantee the delivery of accurate and reliable content to our esteemed readers.